Technogenetics in visita all'Illumina Italy Solution Center per definire insieme le strategie future. Technogenetics e Illumina, una partnership di successo oggi e domani!
👍
Grande Direttore Commerciale. Bel gruppo.
Vai al contenuto principale
Technogenetics in visita all'Illumina Italy Solution Center per definire insieme le strategie future. Technogenetics e Illumina, una partnership di successo oggi e domani!
Consigliere CNEL Presidente Delegato della Giunta del Regolamento del CNEL Consiglio di Presidenza del CNEL Responsabile Dipartimento Sanita’ CIU-Unionquadri
4 mesi👍
Grande Direttore Commerciale. Bel gruppo.
Per visualizzare o aggiungere un commento, accedi
The genesis of our network, the significance of the 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 & 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘁𝗵𝗲𝗺𝗮𝘁𝗶𝗰 𝗮𝗿𝗲𝗮, the key points of the innovation agenda, the collaborative approach among our members, and a case study featuring the 𝗙𝗲𝗺𝘂𝗿 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 by Nippon Gases Italia, Stevanato Group, IRCCS Ospedale Galeazzi - Sant'Ambrogio, and Home Medicine: delve into these topics and more in the in-depth analysis by AboutPharma dedicated to Federated Innovation @MIND. Read the article: https://lnkd.in/e2PH-mPy
Per visualizzare o aggiungere un commento, accedi
We are facing a new wave of change in the way we work. It was great to talk about tech and talents with my MaF and Market Access colleagues #jnjweek #jnjsalute.it
Tecnologia e capitale umano, talenti e competenza del futuro. Ne abbiamo parlato con Selene Vasco, Head of Digital, Business Transformation & Events, Marina Adami, Therapeutic Area Medical Head Neuroscience e Gloriana Granata, PMO Market Access. Scopri di più: jnjsalute.it. #InsiemeVersoLaMedicinaDelFuturo
Per visualizzare o aggiungere un commento, accedi
EzeRx has achieved a remarkable year-on-year growth of 167% with its flagship product, EzeCheck. With a mission to eradicate anemia and empower society, we're revolutionizing the med-tech industry. For the fiscal year 2023–24, the company achieved a net revenue of 10.07 crores while incurring expenses of 3.67 crores, resulting in an impressive EBITDA of 6.4 crores. EzeRx aims to achieve a net revenue of 25.1 crores and an EBITDA margin of 13.05 crores in FY 2024–25. Join us in celebrating EzeRx's success and supporting its mission to transform the med-tech industry for the better. Check out our article to learn more: https://lnkd.in/gXaNgGdN #EzeRx #EzeRxSuccess #MedTechRevolution #EzeCheckEmpowerment #AnemiaEradication #HealthInnovation #EmpoweringSociety #EzeRxGrowth #MedTechTransformation #HealthyFuture #InnovateForGood
Per visualizzare o aggiungere un commento, accedi
🗞 What to read this weekend? I know ! n°1060 is here. #cellprothera #innovation #france2030 #finance BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle
BiotechFinances n°1060 est paru. Excellente lecture et très bon week-end. Les accélérations venez en parler avec nous le 27 juin à Lyon ! N'oubliez pas de vous inscrire aux 25ans de BiotechFinances et à notre premier Healthtech Accelerations Summit ! : https://lnkd.in/eFupMaXt Merci à nos sponsors : #platinium : JEITO, France Biotech, AdBio partners #gold : Research Triangle Park First Flight Venture Center et BIOASTER #silver : HTI - Healthcare & Technology International / Median Technologies
Per visualizzare o aggiungere un commento, accedi
🌟 Embracing the Future with Monocept's Core Values 🌟 At Monocept, we cherish the wisdom that comes with experience, and equally value the fresh perspectives brought by new minds. We believe that true competency is more than just a measure of time; it's a balance of diverse qualities: ✨ Communication - Fostering clear, concise, and effective exchanges. 🔐 Commitment - Our dedication is unwavering, whether it's to our goals or our clients' visions. 💼 Confidence - We empower our team to see challenges as opportunities. ❤️ Passion - The heartbeat of our innovations and solutions. 🧩 Problem Solving - We embrace complexity with strategic and creative thinking. 🚀 Potential - In every team member, we see a universe of possibilities waiting to be explored. At Monocept, every year of experience enriches us, and every new idea propels us forward. Join us on this journey of growth and innovation. 👉 Follow us on our journey of continuous learning and growth in the world of technology. Stay tuned for more insights and updates from Monocept! 🤝 Join us in this exciting journey where experience meets enthusiasm, wisdom intertwines with fresh ideas, and every voice is valued. #monocept #digitalinnovation #teamgrowth #experiencemeetsinnovation #futureready Celebrating every milestone, cherishing every new idea – that's the Monocept way.
Per visualizzare o aggiungere un commento, accedi
📣Luperini Tailored Pharma Machinery COGNITIVE PHARMA MACHINERY #AI line #BROCHURE is online ❗ Download It and learn more about our #COGNITIVE #GRANULATORS & #BLENDERS: machines that can improve their control strategies over time by demonstrating cognitive capabilities, offering several technical innovations that can improve quality and safety. The use of IIoT sensors and AI algorithms in the design stage of these machines mean that they were BORN TO PERFORM #AUTONOMOUSLY AND CONTINUOUSLY IMPROVE their #PERFORMANCE, representing a major improvement over traditional machinery and control systems, which rely on pre-defined rules and a limited amount of data, leading to manual adjustments and an increased risk of operator error. 🎯The incorporation of deep learning algorithms into the control system enabled the system to learn from experience and improve its predictions over time. This resulted in a highly accurate and efficient system that CAN AUTONOMOUSLY DETECT ENDPOINTS and provide real-time feedback to operators, improving the #efficiency, #quality, and #sustainability of #pharmaceutical #manufacturing processes. 💡 This #technology also complies with the Process Analytical Technology (PAT) guidelines, making it a practical embodiment of Pharma 4.0, the fourth industrial revolution in the pharmaceutical industry. 🗝 Click on this link to download the brochure: https://lnkd.in/euemTVdF Need more information or a quote❓ 👉Contact us: LUPERINI TAILORED PHARMA MACHINERY - ITALY ✆0039 .0583.434416 ✉[email protected] 🌐www.luperinipharma.com #pharma #pharma4.0 #food #chemical #handling #granulation #containment #system #process #engineering #artificialintelligence #gmp #italia #madeinitaly #madeinluperini
Per visualizzare o aggiungere un commento, accedi
March Portfolio & Investment News As we approach the end of an eventful Q1, the EMV Capital and NetScientific PLC Group is pleased to share the latest highlights across its deep tech and life sciences portfolio: ➡ Q-Bot Ltd has strengthened its Board with the appointment of Malcolm Groat as its second Investment Director, and a new Executive Chair to be announced shortly. ➡ ProAxsis has appointed EMV Capital and an external adviser to explore options for a potential sale of the company to a new strategic owner to scale the business to its full potential. ➡ SageTech Medical SID-Dock waste volatile anaesthetic gas capture machine was recently installed at NHS Ayrshire & Arran University Hospital Crosshouse and Hull University Teaching Hospitals NHS Trust Castle Hill Hospital. The company is now concentrating on the veterinary market, which represents a significantly higher emissions footprint compared to hospitals. ➡ Vortex Biosciences is focused on generating tightly scoped studies with leading researchers to highlight evidence of the technology to pharma and biotech customers. ➡ PDS Biotechnology has reported its 2023 financial results and outlined its clinical development strategy, which includes Phase 3 plans to address the growing incidence of advanced HPV HNSCC after FDA guidance. ➡ Ventive Limited and Q-Bot Ltd exhibited at the Futurebuild 2024 conference, where they showcased their innovative built environment solutions. 👇 Subscribe to our newsletter for more insights and updates: https://lnkd.in/etxzjW6J #deeptech #lifesciences #venturecapital #investmentportfolio
Per visualizzare o aggiungere un commento, accedi
At Monocept, we live by the mantra "change is the only constant." In our dynamic industry, this belief is more relevant than ever. Innovation is the heartbeat of our operations, driving us to explore new technologies and methodologies. Adaptability is our strength, allowing us to pivot and thrive amid rapid changes and emerging trends. Our commitment to continuous evolution ensures that we are not just keeping pace with the industry but setting the standard for excellence. By embracing change, we navigate the present with confidence and shape the future with purpose. This approach enables us to deliver cutting-edge solutions that meet and exceed our clients' needs. At Monocept, change isn't just a challenge—it's an opportunity to grow, improve, and lead. Join us on this journey as we continue to innovate and adapt, ensuring we remain at the forefront of technological advancement. #Innovation #Adaptability #TechLeadership #Monocept
Per visualizzare o aggiungere un commento, accedi
EMEA Sr Channel Manager at Illumina
4 mesiWas nice to having you in our facilities and align on actions and plans to serve our customers and grow further together!